Wu K

Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221004, China. Electronic address: kunwei.wu@xzhmu.edu.cn.

8 papers

ArticleKetamine

The Immunomodulatory Landscape of Anesthetic Agents: Mechanisms, Clinical Implications, and Therapeutic Potential.

Ye J, Deng M, Liao Y +4

Europe PMC2026
ArticleKetamine

Propofol for depression: mechanisms and therapeutic potential.

Yu D, Liao Y, Li J +5

Europe PMC2026
ArticleKetamine

Descriptive oxidative and lipid-related fluorescence observations associated with Esketamine treatment in a high-concentration NMDA-exposed HT-22/C8-D1A co-culture model.

Ni X, Zhou S, He X +4

Europe PMC2026
ArticleKetamine

Neurodevelopmental and behavioral effects of early-life esketamine hydrochloride exposure in zebrafish (Danio rerio).

Zheng S, Du T, Wu K +1

Europe PMC2026
ArticleDMT

Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT<sub>1A</sub> Receptor for Therapeutic Potential in Depression and Anxiety.

Li SJ, Yuan QN, Wu WY +14

Europe PMC2025
ArticleKetamine

Ecotoxicological risk assessment of the novel psychoactive substance Esketamine: Emphasis on fish skeletal, behavioral, and vascular development.

Zhang Q, Wu T, Luo C +5

Europe PMC2024
ArticleKetamine

Esketamine alleviates ferroptosis-mediated acute lung injury by modulating the HIF-1α/HO-1 pathway.

Shi J, Song S, Wang Y +4

Europe PMC2024
ArticleKetamine

Mapping metabolite change in the mouse brain after esketamine injection by ambient mass spectrometry imaging and metabolomics.

Liu GX, Li ZL, Lin SY +5

Europe PMC2023